
Atrasentan in Patients With Advanced Renal Cell Carcinoma: A Phase 2 Trial of the ECOG-ACRIN Cancer Research Group (E6800)
Keywords: سرطان کلیه ; Bone metastases; Endothelin A receptor antagonist; Kidney cancer; Pain palliation; Progression-free survival;